|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02327 MEILLEUREHEALTH
Nominal 
0.265 +0.017 (+6.855%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 36,518 | -27.938% | 50,676 | 129,304 | 119,894 | 253,031 |
| Cost of Sales | (13,887) | -36.213% | (21,771) | (51,214) | (53,133) | (152,102) |
| Gross Profit | 22,631 | -21.706% | 28,905 | 78,090 | 66,761 | 100,929 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | 21,727 | -8.760% | 23,813 | 20,086 | 13,581 | 15,190 | |
| Change in FV & Impairment on Others | (854) | -95.777% | (20,224) | (3,962) | -- | -- | |
| Profit / (Loss) on Disposal | 8,558 | -- | -- | 3,900 | 9,435 | 14,844 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (4,116) | 36.472% | (3,016) | (4,353) | (14,774) | (11,068) | |
| Profit / (Loss) before Taxation | 30,537 | -32.739% | 45,401 | 52,983 | 25,385 | 85,704 | |
| Taxation | 7,461 | -- | (13,356) | (14,493) | (7,605) | (25,248) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (15) | -- | 435 | 2,340 | 42 | (133) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 37,983 | 16.943% | 32,480 | 40,830 | 17,822 | 60,323 | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (20,013) | 70.309% | (11,751) | (7,416) | (15,460) | (4,064) |
| Depreciation & Amortisation | 1,097 | -32.741% | 1,631 | 2,639 | 3,852 | 3,576 |
| Directors' Emoluments | -- | -- | 2,585 | 1,693 | 2,614 | 3,938 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.930 | 17.722% | 0.790 | 1.000 | 0.430 | 1.420 |
| DPS (cts) | 0.550 | -- | 0.400 | 0.400 | 1.600 | 0.000 |
| Dividend Payout Ratio (%) | 59.140% | -- | 50.633% | 40.000% | 372.093% | -- |
| Cash flow per share ($) | -- | -- | 0.045 | (0.033) | 0.011 | (0.020) |
| NBV per share ($) | 0.305 | -- | 0.294 | 0.306 | 0.323 | 0.339 |
| Remarks: | Real time quote last updated: 10/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 37,983 |
| %Change | 16.943% |
| EPS / (LPS) | HKD 0.009 |
| NBV Per Share ($) | HKD 0.305 |